Holen Sie sich die Stockscreener-App
77.77
0.75%
0.58
Handel nachbörslich:
77.77
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EW?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$77.19
Offen:
$77.14
24-Stunden-Volumen:
3.78M
Relative Volume:
0.89
Marktkapitalisierung:
$45.66B
Einnahmen:
$5.69B
Nettoeinkommen (Verlust:
$1.41B
KGV:
11.19
EPS:
6.95
Netto-Cashflow:
$577.90M
1W Leistung:
+4.29%
1M Leistung:
-4.39%
6M Leistung:
+9.67%
1J Leistung:
+17.85%
1-Tages-Spanne:
$76.78
$78.15
1-Wochen-Bereich:
$73.70
$78.15
52-Wochen-Spanne:
$64.00
$83.00
Edwards Lifesciences Corp Stock (EW) Company Profile
Firmenname
Edwards Lifesciences Corp
Sektor
Branche
Telefon
(949) 250-2500
Adresse
ONE EDWARDS WAY, IRVINE, CA
Vergleichen Sie EW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
77.77 | 45.32B | 5.69B | 1.41B | 577.90M | 6.95 |
|
ABT
Abbott Laboratories
|
133.94 | 231.67B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.63 | 143.79B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
369.67 | 141.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.24 | 120.53B | 34.20B | 4.69B | 5.30B | 3.63 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-29 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-04-24 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Stifel | Hold → Buy |
| 2025-01-16 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-11 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-09-18 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-31 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-07-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-07-25 | Herabstufung | Truist | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-05-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-03-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-02-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-28 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | Herabstufung | Bernstein | Outperform → Underperform |
| 2023-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | Herabstufung | Stifel | Buy → Hold |
| 2022-10-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-10-26 | Eingeleitet | Mizuho | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-29 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-27 | Bestätigt | Citigroup | Buy |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Raymond James | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | UBS | Neutral |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-12-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | Bestätigt | Canaccord Genuity | Buy |
| 2021-07-30 | Bestätigt | Deutsche Bank | Hold |
| 2021-07-30 | Bestätigt | Jefferies | Buy |
| 2021-07-30 | Bestätigt | Morgan Stanley | Overweight |
| 2021-07-30 | Bestätigt | Oppenheimer | Outperform |
| 2021-07-30 | Bestätigt | Stifel | Buy |
| 2021-07-30 | Bestätigt | UBS | Neutral |
| 2021-07-30 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Neutral |
| 2021-04-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-11 | Bestätigt | Canaccord Genuity | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Underperform |
| 2020-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Neutral |
| 2020-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-10-24 | Bestätigt | Canaccord Genuity | Buy |
| 2019-09-23 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-07-24 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-18 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-10-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | Herabstufung | Guggenheim | Buy → Neutral |
Alle ansehen
Edwards Lifesciences Corp Aktie (EW) Neueste Nachrichten
One Wealth Advisors LLC Sells 9,296 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
EW Investor News: If You Have Suffered Losses in Edwards - GlobeNewswire
Will Edwards Lifesciences Corporation stock return to pre crisis levelsRate Hike & Risk Managed Investment Entry Signals - newser.com
Edwards Lifesciences Corporation $EW Shares Sold by Capital Insight Partners LLC - MarketBeat
Wall Street Zen Downgrades Edwards Lifesciences (NYSE:EW) to Buy - MarketBeat
Edwards Lifesciences Corporation EWL Stock Analysis and ForecastRSI Overbought/Oversold & Get Tomorrow’s Winners Today With AI - earlytimes.in
What drives Edwards Lifesciences Corporation EWL stock pricePortfolio Risk Assessment & Fast Profit Trading Ideas - earlytimes.in
EW Investor News: If You Have Suffered Losses in Edwards Lifesciences Corporation (NYSE: EW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Banque Pictet & Cie SA Trims Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Bank Pictet & Cie Europe AG Purchases 15,004 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW - Business Wire
CHICAGO TRUST Co NA Grows Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Swedbank AB - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by BDF Gestion - MarketBeat
Diversified Trust Co Buys 4,454 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
MassMutual Private Wealth & Trust FSB Decreases Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
The Returns On Capital At Edwards Lifesciences (NYSE:EW) Don't Inspire Confidence - Yahoo Finance
Stifel Lowers Price Target for Edwards Lifesciences (EW) to $85 - GuruFocus
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $95, Maintains Buy Rating - MarketScreener
Edwards Lifesciences price target lowered to $85 by Stifel on TAVR data concerns - Investing.com
NorthCrest Asset Manangement LLC Takes $330,000 Position in Edwards Lifesciences Corporation $EW - MarketBeat
Wealth Enhancement Advisory Services LLC Buys 86,186 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Purchased by Czech National Bank - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Sees Significant Increase in Short Interest - MarketBeat
Performance Recap: Does Energy Fuels Inc. stock reflect fundamentalsJuly 2025 Institutional & Community Verified Watchlist Alerts - khodrobank.com
Aug PreEarnings: How sensitive is Edwards Lifesciences Corporation to inflation2025 Market Outlook & Weekly Stock Breakout Alerts - خودرو بانک
Edwards Lifesciences Corporation $EW Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Aug Movers: Whats the outlook for Edwards Lifesciences Corporations sectorEntry Point & Growth Oriented Trade Recommendations - khodrobank.com
Edwards Lifesciences Corporation $EW Shares Sold by Bowman & Co S.C. - MarketBeat
Seilern Investment Management Ltd Has $96.89 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (EW): A Bull Case Theory - Yahoo Finance
Capital Asset Advisory Services LLC Acquires Shares of 5,853 Edwards Lifesciences Corporation $EW - MarketBeat
Neville Rodie & Shaw Inc. Sells 3,522 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Treasury Yields: Will Edwards Lifesciences Corporation outperform its industry peersLong Setup & Fast Moving Trade Plans - خودرو بانک
Analysis Recap: Whats the outlook for Edwards Lifesciences Corporations sectorGold Moves & Real-Time Volume Triggers - khodrobank.com
Aug Rallies: What makes WLDSW stock attractive today2025 Breakouts & Breakdowns & Weekly Return Optimization Alerts - khodrobank.com
Swedbank AB Decreases Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Caxton Associates LLP Buys Shares of 5,110 Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) Lowered to Buy Rating by Wall Street Zen - MarketBeat
Acadian Asset Management LLC Grows Stake in Edwards Lifesciences Corporation $EW - MarketBeat
E. Ohman J or Asset Management AB Takes $2.04 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Intech Investment Management LLC Cuts Position in Edwards Lifesciences Corporation $EW - MarketBeat
Militia Capital Partners LP Sells 60,000 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Stake Raised by Howe & Rusling Inc. - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Edwards Lifesciences Stock: Analyst Estimates & Ratings - MSN
NewEdge Advisors LLC Has $2.39 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Trading Recap: Is Edwards Lifesciences Corporations growth already priced inJuly 2025 Weekly Recap & Weekly Watchlist for Hot Stocks - خودرو بانک
Pacific Capital Partners Ltd Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Glenview Trust co Decreases Position in Edwards Lifesciences Corporation $EW - MarketBeat
Finanzdaten der Edwards Lifesciences Corp-Aktie (EW)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.75%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):